teriparatide
NDC 47781-652, teriparatide, injection, solution, from Alvogen, Inc..
- Product NDC
- 47781-652
- Status
- Listed
- Labeler
- Alvogen, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211939
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47781-652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERIPARATIDE250 ug/mL
Pharmacologic classes
Parathyroid Hormone Analog [EPC]; Parathyroid Hormone [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-652-89 | 47781065289 | 1 SYRINGE in 1 CARTON (47781-652-89) / 2.24 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1b007339-dd0d-f019-5e0a-9b1b0f75011cNADAC price for package 47781065289
GET /v1/drugs/nadac/47781065289
Use it
Look up 47781-652 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-652. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.